WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 10,68 | 10,68 | 2021-09-30 |
| Nordnet Pensionsförsäkring | 4,89 | 4,89 | 2021-09-30 |
| Linfan Zhang | 4,89 | 4,89 | 2021-09-30 |
| Gunvald Berger | 2,05 | 2,05 | 2021-09-30 |
| Youplus Assurance AG | 1,73 | 1,73 | 2021-09-30 |
| Thomas Mellqvist | 1,52 | 1,52 | 2021-09-30 |
| Kjell Stenberg | 1,51 | 1,51 | 2021-09-30 |
| Lars-Erik Forsgårdh | 1,19 | 1,19 | 2021-09-30 |
| Niclas Evertsson | 1,16 | 1,16 | 2021-09-30 |
| Claes Sjölund | 1,14 | 1,14 | 2021-09-30 |
2021-11-18 Delårsrapport 2021-Q3
2022-02-24 Bokslutskommuniké 2021